Vitrolife AB (publ)

    Jurisdiction
    Sweden
    LEI
    5493001WDZMONMSPPR49
    ISIN
    SE0011205202 (VITR.ST)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    €7.42 72.4% overvalued
    Financial strength (Piotroski F-Value)
    9 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. Read full profile

    Fundamentals

    Net revenue
    €316.93M
    Gross margin
    58.8%
    EBIT
    €61.52M
    EBIT margin
    19.4%
    Net income
    €40.75M
    Net margin
    12.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A N/A
    €360.88M €61.68M
    €387.16M +7.3% €65.78M +6.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    SEK 1.10
    Ex date
    Payment date
    Dividend payout ratio
    32.7%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications